Möchten Sie immer auf dem neuesten Stand bleiben?

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions (June 10, 2026)" training has been...

EDMONTON, Alberta , April 09, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, intends to present a full suite of...

MicrobiotiX and WAFCIRC sign MoU and Research Collaboration Agreement in Ghana, launching clinical research to evaluate phage therapy for AMR infections.

EDMONTON, Alberta , Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, is presenting four posters at the...

Munich, Germany, Jan. 20, 2026 (GLOBE NEWSWIRE) -- smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the in-licensing of a new...

Edmonton, Alberta, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans to unveil the...

Dublin, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The "Staphylococcus Aureus Bacteremia Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and...

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Acute Bacterial Skin and Skin Structure Infection Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast,...

Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a platform of small-molecule enzymatic activators that induce self-digestion...

-- Existing and new investors joining forces to support the accelerated development of Omnix´s novel, first-in-class antimicrobials pipeline -- Funding underlines urgent global need for novel,...